Drugs

Exam Prep

Glossary

Handouts

SchoolsNew

Contact Lenses Medications Glossary Calculators Handouts Exam Prep

Disclaimer Privacy Policy Terms of Use Contact

Educational resource only — not medical advice. Independent study tool, not affiliated with or endorsed by the NBEO®. See our Disclaimer.

Medications›Misc.›Imuran

Imuran®

GoodRx

Azathioprine · oral tablet

Misc.

Approved uses

Prevention of rejection in renal transplantation

Usually 3 to 5 mg/kg daily at the time of transplant, then 1 to 3 mg/kg daily as maintenance

Active rheumatoid arthritis

Initially about 1 mg/kg daily, increased after 6 to 8 weeks and then at 4-week intervals to a maximum of 2.5 mg/kg daily

Test TPMT and NUDT15 before starting: a deficient patient can be catastrophically myelosuppressed at an ordinary dose

OFF-LABELNot in the FDA label for this product

Non-infectious uveitis, scleritis and mucous membrane pemphigoid

Oral, as the sole non-corticosteroid agent; several months before the effect is judged

Cohort · n=145 · slow, 62%

A retrospective cohort of 145 patients starting azathioprine as their only non-corticosteroid agent found 62% gained sustained complete inactivity of inflammation within a year and 47% got prednisone down to 10 mg a day or less while holding control. It suited intermediate uveitis best, where 90% reached sustained inactivity within a year. The two cautions are that it is slow, needing several months to reach its goal, and that roughly a quarter of patients hit a treatment-limiting side effect within the year, though these were typically reversible.

Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148(4):500-509

Contraindications

Other Misc. drugs

Actemra®
Betadine® 5%
Botox®
CellCept®
Cystadrops®
Cystaran®
Epioxa®
Fluorouracil

Browse all medications All Misc. drugs

Azathioprine tablets should not be given to patients who have shown hypersensitivity to the drug. Azathioprine tablets should not be used for treating rheumatoid arthritis in pregnant women. Patients with rheumatoid arthritis previously treated with alkylating agents (cyclophosphamide, chlorambucil, melphalan, or others) may have a prohibitive risk of malignancy if treated with azathioprine tablets.

Available Forms

Azathioprine 50 mg tablets.

Mechanism of Action

Azathioprine is a purine antimetabolite. It is converted to 6-mercaptopurine and then to thioguanine nucleotides, which are incorporated into DNA and suppress the proliferation of rapidly dividing lymphocytes, damping the cell-mediated immune response.

Warnings & Precautions

Chronic immunosuppression with azathioprine increases the risk of malignancy, including post-transplant lymphoma and hepatosplenic T-cell lymphoma. This carries a boxed warning.
Severe myelosuppression can occur, particularly in patients with reduced TPMT or NUDT15 activity; test before starting and monitor the blood count.
Serious infections, including opportunistic infection, may occur.
Gastrointestinal hypersensitivity presenting as severe nausea and vomiting can occur within the first weeks.

Common Side Effects

The principal and potentially serious toxic effects of azathioprine tablets are hematologic and gastrointestinal. The risks of secondary infection and malignancy are also significant (see WARNINGS ). The frequency and severity of adverse reactions depend on the dose and duration of azathioprine tablets as well as on the patient's underlying disease or concomitant therapies.

Pregnancy & Lactation

Pregnancy: Azathioprine can cause fetal harm; it crosses the placenta and has been associated with intrauterine growth restriction and neonatal myelosuppression.

Lactation: Azathioprine metabolites are present in human milk; a decision should weigh the mother's clinical need against the potential risk.

Pediatric Use

Safety and efficacy of azathioprine in pediatric patients have not been established.

Imuran (Azathioprine) | EyeKnow O.D.